Form 4: NeuroPace CFO Rebecca Kuhn Reports Acquisition of Shares and Stock Options

Rebecca Kuhn, CFO of NeuroPace Inc, reports the acquisition of 11,700 shares of common stock and 19,850 stock options on March 10, 2025.

Summary

• On March 10, 2025, Rebecca Kuhn, the Chief Financial Officer of NeuroPace Inc, reported acquiring 11,700 shares of common stock represented by restricted stock units (RSUs) at a price of $0.
• These RSUs vest with 25% vesting on March 3, 2026, and the remaining RSUs vesting in twelve equal quarterly installments thereafter.
• Kuhn also acquired 19,850 stock options with an exercise price of $10.04.
• 25% of the shares subject to the option vest on March 3, 2026, with the remaining shares vesting in thirty-six equal consecutive monthly installments thereafter.
• Following these transactions, Kuhn directly owns 136,595 shares of common stock and 19,850 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard insider transaction report. The acquisition of shares and options could be seen as a slightly positive sign, but it's not definitive.

Positives

• The CFO's acquisition of shares and options could be interpreted as a positive signal, indicating confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies and their insiders. It provides transparency into the transactions of company executives.

Stakeholder Impact

• The CFO's stock transactions may influence investor sentiment.

Key Dates

Keywords

NeuroPace, NPCE, Form 4, SEC Filing, Insider Trading, Rebecca Kuhn, CFO, Stock Options, Restricted Stock Units, RSU, Common Stock, Beneficial Ownership